ToxSci Advance Access originally published online on May 2, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 74, 85-92 (2003)
Copyright © 2003 by the Society of Toxicology
IMMUNOTOXICOLOGY |
7,12-Dimethylbenz[a]anthracene-Induced Bone Marrow Toxicity Is p53-Dependent
,
,1
* Department of Pathobiological Sciences,
Department of Pharmacology, and
Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin 53706
Polycyclic aromatic hydrocarbons (PAHs) are known immunotoxins and carcinogens. Our laboratory and others have demonstrated that metabolism of these compounds by CYP1B1 is required for carcinogenicity and immunotoxicity to occur. Previously, our laboratory reported significantly decreased bone marrow cellularity in mice following 7,12-dimethlybenz[a]anthracene (DMBA) administration. In addition, we have observed that DMBA causes apoptosis via activation of both caspase-8 and -9 in pre-B cells co-cultured with bone marrow stromal cells in vitro. In this study, we investigated the importance of the p53 protein in the bone marrow response to DMBA. Through the use of p53 gene knockout mice, we demonstrated that the effect of DMBA on bone marrow cellularity is p53-dependent. In addition, apoptosis of primary cultures of progenitor B cells cultured with bone marrow stromal cells and DMBA is also p53-dependent. The results of this study provide evidence for the importance of p53 in the signaling pathways by which PAHs cause immunotoxicity.
Key Words: PAH; DMBA; apoptosis; B cell; bone marrow; p53.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Gao, L. A. Mitchell, F. T. Lauer, and S. W. Burchiel p53 and ATM/ATR Regulate 7,12-Dimethylbenz[a]anthracene-Induced Immunosuppression Mol. Pharmacol., January 1, 2008; 73(1): 137 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Nebert Comparison of gene expression in cell culture to that in the intact animal: relevance to drugs and environmental toxicants. Focus on "Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes" Am J Physiol Cell Physiol, January 1, 2006; 290(1): C37 - C41. [Full Text] [PDF] |
||||
![]() |
J. Gao, F. T. Lauer, S. Dunaway, and S. W. Burchiel Cytochrome P450 1B1 Is Required for 7,12-Dimethylbenz(a)-anthracene (DMBA) Induced Spleen Cell Immunotoxicity Toxicol. Sci., July 1, 2005; 86(1): 68 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Stewart, T. D. Querec, A. R. Ochman, B. N. Gruver, R. Bao, J. S. Babb, T. S. Wong, T. Koutroukides, A. D. Pinnola, A. Klein-Szanto, et al. Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia Cancer Res., November 15, 2004; 64(22): 8177 - 8183. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Nebert, T. P. Dalton, A. B. Okey, and F. J. Gonzalez Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer J. Biol. Chem., June 4, 2004; 279(23): 23847 - 23850. [Abstract] [Full Text] [PDF] |
||||




